N.Y. Comp. Codes R. & Regs. tit. 9 § 4120.3

Current through Register Vol. 46, No. 16, April 17, 2024

Section 4120.3 - Equine drug thresholds; per se

(a) A horse shall have raced in violation of this section if any of the following substances is found, by the laboratory conducting tests for the commission, to be present in a race-day urine or blood sample taken from such horse at a concentration in excess of a threshold listed below. The test result of such laboratory shall include an assessment of the measurement uncertainty and imprecision of the quantitative threshold for the substance.

(1) Acepromazine: 10 ng/ml HEPS in urine;

(2) Albuterol: 1 ng/ml in urine;

(3) Butorphanol:

(i) 300 ng/ml of total butorphanol in urine; or

(ii) 2 ng/ml of free butorphanol in plasma;

(4) Cetirizine: 6 ng/ml in plasma;

(5) Cimetidine: 400 ng/ml in plasma;

(6) Cobalt: 50 ng/ml in plasma;

(7) Dantrolene: 100 pg/ml of 5-hydroxydantrolene in plasma;

(8) Detomidine:

(i) 2 ng/ml of any metabolite of detomidine in urine; or

(ii) 1 ng/ml of detomidine in plasma;

(9) Diclofenac: 5 ng/ml in plasma;

(10) DMSO: 10 mcg/ml in plasma;

(11) Firocoxib: 20 ng/ml in plasma;

(12) Flunixin: 20 ng/ml in plasma;

(13) Furosemide: 100 ng/ml in plasma and a specific gravity of urine less than 1.010;

(14) Glycopyrrolate: 3 pg/ml in plasma;

(15) Guaifenesin: 12 ng/ml in plasma;

(16) Ketoprofen: 2 ng/ml in plasma;

(17) Lidocaine: 20 pg/ml of total 3-hydroxylidocaine in plasma;

(18) Mepivacaine:

(i) 10 ng/ml of total hydroxymepivacaine in urine; or

(ii) any hydroxymepivacaine in plasma;

(19) Methocarbamol: 1 ng/ml in plasma;

(20) Methylprednisolone: 100 pg/ml in plasma;

(21) Omeprazole: 10 ng/ml of omeprazole sulfide in plasma;

(22) Phenylbutazone: 2 mcg/ml in plasma;

(23) Procaine penicillin: 25 ng/ml of procaine in plasma;

(24) Ranitdine: 40 ng/ml in plasma; and

(25) Xylazine: 200 pg/ml in plasma.

(b) A laboratory finding that a horse has not exceeded a threshold set forth in this section shall not constitute a defense to a violation of any other section of this Subchapter.

(c) A person who is found responsible for a violation of this section for the substance cobalt, when the detected concentration of cobalt exceeds 300 ng/ml in plasma, shall incur the same penalty described in paragraph (2) of subdivision (d) of section 4120.17 of this Part.

N.Y. Comp. Codes R. & Regs. Tit. 9 § 4120.3

Adopted, New York State Register January 21, 2015/Volume XXXVII, Issue 03, eff.4/1/2015

Amended New York State Register February 10, 2016/Volume XXXVIII, Issue 06, eff.2/10/2016

Amended New York State Register June 2, 2021/Volume XLIII, Issue 22, eff. 6/2/2021